A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.
Choi, S., Reixach, N., Connelly, S., Johnson, S.M., Wilson, I.A., Kelly, J.W.(2010) J.Am.Chem.Soc. 132: 1359-1370
- PubMed: 20043671 
- DOI: 10.1021/ja908562q
- Primary Citation of Related Structures:  
- PubMed Abstract: 
Transthyretin aggregation-associated proteotoxicity appears to cause several human amyloid diseases. Rate-limiting tetramer dissociation and monomer misfolding of transthyretin (TTR) occur before its aggregation into cross-beta-sheet amyloid fibrils. ...